Skip to main content
BMJ Case Reports logoLink to BMJ Case Reports
. 2022 Mar 29;15(3):e247760. doi: 10.1136/bcr-2021-247760

Kinesigenic dyskinesias after ENT surgery misdiagnosed as focal epilepsy

Selina Denise Trapp 1,, Soheyl Noachtar 2, Elisabeth Kaufmann 1
PMCID: PMC8966546  PMID: 35351750

Abstract

We describe a man in his 30s who presented with paroxysmal right-sided dyskinesias of the arm and neck, misdiagnosed with drug-resistant focal epilepsy. Two months earlier he had undergone surgery for chronic sinusitis. Immediately after this procedure, he developed hemiparesis, hemiataxia, paresthesias and disturbances in verbal fluency. Cranial MRI revealed a disruption of the left lamina cribrosa and an intracerebral injury resembling a branch canal spanning to the left dorsal third of the thalamus. Single-photon emission tomography imaging demonstrated malperfusion of the left ventral thalamus, left-sided cortex and right cerebellar hemisphere. During continuous video-EEG monitoring, three dyskinetic episodes with tremor of the right arm and dystonia of the finger and shoulder could be recorded. The paroxysmal dyskinesias did not improve with carbamazepine, valproate and tiapride. This case demonstrates an unusual symptomatic cause of a thalamic movement disorder misdiagnosed as focal epilepsy and highlights the postoperative complications, diagnostic and treatment efforts.

Keywords: neurology (drugs and medicines), neurology, epilepsy and seizures, movement disorders (other than Parkinson's), neurological injury

Background

It is well established that thalamic lesions may lead to various symptoms including sensorimotor deficits and movement disorders.1–3 However, reports about iatrogenic thalamic lesions are scarce. Here, we present a patient with a thalamic movement disorder, in whom the iatrogenic thalamic lesion manifested as a complication of ear, nose and throat (ENT) surgery.

Case presentation

The patient’s complaints were a paroxysmal right-sided tremor and dyskinesias occurring about three times a day for 2 months, in particular when exerting strenuous activities. Transient right-sided paresis and paresthesias for 4 months occurred immediately after ENT surgery for chronic sinusitis.

Four months prior to admission, an ENT surgery for chronic sinusitis with septum plastic, bilateral conchotomy, polyp removal and endoscopic supported pansinusitis surgery had been performed. Immediately after surgery the patient reported paresthesias and right-sided hemiparesis. The hemiparesis improved over the course of weeks but did not subside completely. Two months after the surgery, rhythmic jerks of the right arm and right side of the neck occurred three times a day for several minutes. The patient was referred to a regional hospital, where an epileptic origin of the ‘convulsions’ was suspected resulting in a prescription of carbamazepine 800 mg/day.

As the rhythmic jerks continued, the patient was admitted to the epilepsy centre of the regional university hospital, where right-sided hemiparesis, paresthesias and anosmia were documented. At this point in time, three to six times a day, paroxysmal, rhythmical dyskinetic attacks of 1–2 min duration in the right hand and occasionally also in the whole right arm occurred. Most attacks were provoked by strenuous motor activities.

Investigations

Clinical examinations and motor evoked potentials yielded no evidence supporting a lesion of the pyramidal tracts. Somatosensory evoked potentials indicated central axonal damage after right-sided stimulation (figure 1). Neuropsychological examination showed a severe deficit in verbal memory and fluency. A video electroencephalography (EEG) of 8 hours duration showed three dyskinetic episodes with tremor of the right arm and dystonia of the fingers and partly the shoulder. Two episodes were provoked by kneading a foam cushion wedge with the right arm and one episode occurred spontaneously. The tremor increased when holding up the arm or when attempting aimed movements and completely remitted by resting the arm (Video 1). The EEG showed no signs of event-related potentials.

Figure 1.

Figure 1

Somatosensory evoked potential (SEP) results reflect the left thalamic lesion.

Video 1.

DOI: 10.1136/bcr-2021-247760.video01

During one dyskinetic episode, 4 s after onset, a technetium-99m (99mTc) tracer was injected for single-photon emission tomography (SPECT) imaging. The 99mTc-SPECT imaging reflects the cerebral perfusion state around the time of injection and revealed a malperfusion of the left ventral thalamus, left-sided cortex and a crossed cerebellar diaschisis, that is, a hypoperfusion of right cerebellar hemisphere. CT imaging showed an approximately 5 mm wide disruption of the left lamina cribrosa. MRI demonstrated a bony defect in the left gyrus rectus adjoining an approximately 4,5 cm long intracerebral lesion spanning to the dorsal third of the thalamus in the area of the corticospinal tract with some bleeding residues (figures 2 and 3).

Figure 2.

Figure 2

T2-weighted MRI imaging in coronal plane demonstrating an intracerebral defect in the left gyrus rectus.

Figure 3.

Figure 3

Gradient echo-weighted MRI imaging in axial plane demonstrates the intracerebral lesion spanning to the dorsal third of the left thalamus with some bleeding residues.

Differential diagnosis

As the EEG showed no signs of epilepsy and the patient was able to partly suppress and induce the dyskinesias of the arm, focal epilepsy was an unlikely differential diagnosis. The dyskinetic movements may be classified as kinesigenic dyskinesias or a dystonic tremor. However, the kinesigenic dyskinesia is more likely as the lesion also involved the left subthalamic nucleus. The nucleus subthalamicus sends inhibitory signals to the inhibitory motor parts of the globus pallidum leading to suppression of the ventroanterior and ventrolateral nuclei of the thalamus. Therefore, a lesion of the nucleus subthalamicus may result in hyperkinetic symptoms on the contralateral side.

Treatment

Valproate was started and as soon as its target concentration of 50–100 µg/mL was reached, carbamazepine was discontinued due to lack of symptom improvement. The patient stayed at a rehabilitation hospital on three separate occasions. According to the patient, neither of the two medications nor tiapride improved the attacks but caused side effects such as dizziness, leading to the discontinuation of the drugs.

For paroxysmal kinesigenic dyskinesias, sodium channel blockers such as carbamazepine are the recommended treatment.4–7 Especially in patients with primary paroxysmal kinesigenic dyskinesias, which are considered to be hereditary, carbamazepine has shown good effects.8 However, in secondary paroxysmal kinesigenic dyskinesias like our case, sodium channel blockers have not shown similarly consistent results.7 Yet, some case reports show good efficacy of carbamazepine in improving dyskinesias secondary to thalamic lesions caused by stroke and multiple sclerosis.9 10 There are scarce reports about valproate treatment in paroxysmal kinesigenic dyskinesias and even in those reports, it was not the first choice of treatment.4 7

Outcome and follow-up

The kinesigenic dyskinesias slightly improved spontaneously, as the dyskinesias in the right arm occurred less frequently over time. However, 18 years later, the patient still suffers from right-sided fine motor difficulties, as well as right-sided paresthesias and slight weakness. As the patient is right-handed, he learnt to use his left hand predominantly. He works part-time as a caregiver in an institution for people with disabilities.

Discussion

Thalamic movement disorders may phenotypically present as dyskinesias, which may be further classified into subcategories such as dystonia, chorea, (haemi-)ballism, athetosis, tremor, myoclonus or asterixis.11–14

We discuss a rare case of a man in his 30s with thalamic movement disorder presenting as kinesigenic dyskinesias after iatrogenic thalamic damage due to ENT surgery.

The thalamus is considered the relay station for information processing through the brain as it receives afferent fibers from basal ganglia and cerebellum and sends projections to the cortex (figure 4).15 Disturbance of the cerebellar-thalamic loop and the cortico-striato-pallido-thalamo-cortical loop can lead to a loss of inhibition at cortical level and cause movement disorders.11 16–19 A lesion of the nucleus subthalamicus may impair inhibition of thalamus and result in dyskinesias.20

Figure 4.

Figure 4

The simplified sketch shows the cerebello-thalamic loop on the left and the cortico-striato-pallido-thalamo-cortical loop on the right. The green arrows demonstrate glutamatergic excitation and the red arrows with a blunt end GABAergic (y-aminobutyric acid-ergic) inhibition. The red blizzard icons symbolise the lesion locations in our patient. Globus pallidus ext., globus pallidus externus; globus pallidus int., globus pallidus interneus; Nuc. subthalamicus, nucleus subthalamicus. The figure was created by SDT.

As neuroanatomy dictates, in the thalamus dyskinesias are described to mainly originate from damage to the ventroanterior, ventrolateral,17 posterior, posterolateral14 21 and dorsolateral thalamic nuclei.22

Kinesigenic dyskinesias present with dyskinetic movements triggered by voluntary movement typically involving the extremities.23 24 Similar to our case, acquired thalamic lesions have been described to cause dyskinesias months after damage;13 25 however, most frequently, those lesions are of vascular origin.1–3 There are only limited reports about iatrogenic thalamic lesions. One case report describes three tremor patients who permanently suffered from dystonia after radiofrequency thalamotomy and deep brain stimulation (DBS) to the right nucleus ventralis intermedius.18 Further, dyskinesia is a known, rare and usually reversible complication of DBS of the subthalamic nucleus.20 26 On the other side, strategic lesioning of the internal part of globus pallidus internus or subthalamic nucleus or functional lesioning using DBS has been established as treatment option for treatment-resistant movement disorders including dyskinesia.27 28 This suggests that maybe the aetiology, precise location and especially size of the thalamic lesion might be crucial for the induction or improvement of dyskinesia.

A retrospective study examined 29 patients with Holmes tremor and observed that all included patients with dystonia (n=16) showed thalamic involvement. Besides dystonia, they also presented hemiparesis (75%), hypesthesia (25%) and cerebellar symptoms (25%).29 Similarly, our patient presented with right-sided hemiparesis which may be explained by axonal damage of the corticospinal tract. As the thalamus receives sensory signals from spinothalamic tract and afferences from sensory cranial nerves, damage may also lead to right-sided paresthesias. The crossed cerebellar diaschisis causes a phenomenon of cerebellar malperfusion secondary to contralateral thalamic damage and possibly explains the right-sided hemiataxia of this patient.30

Neuropsychological examination revealed verbal memory and fluency deficits in this patient, possibly caused by the malperfusion in the area of the ventral anterior thalamus due to the lesion spanning until the dorsal thalamus. Several studies have suggested an association of Broca’s area and ventral anterior nucleus of the thalamus.31–33

Medical treatment typically includes carbamazepine as first-line therapy which has good effect in primary paroxysmal kinesigenic dyskinesias, but was shown to be less effective in those with a secondary cause, similar to our case.4–7 Furthermore, phenytoin,5 6 34 topiramate34 35 and zonisamide36 were in some cases successfully used in doses lower than typically used for epileptic seizures. Acetazolamide,5 6 37 levodopa, tetrabenazine and trihexyphenidyl hydrochloride5 37 have similarly shown promising results, although in a limited number of cases.

Learning points.

  • Complications of ENT surgery may cause thalamic movement disorders.

  • Unclassified movement disorders may require multimodal evaluation including video-EEG monitoring.

  • Ventral thalamic lesions may cause kinesigenic dyskinesias.

Footnotes

Contributors: SDT prepared the manuscript draft and the figures. EK and SN revised the manuscript critically for intellectual content. SN evaluated and treated the patient. All authors made substantial contributions to the conception of the work and gave the final approval of the version to be published.

Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

Competing interests: EK and SDT have no conflict of interest. SN reports personal fees from Desitin, UCB Pharma, Medtronic, Eisai and Zogenix.

Provenance and peer review: Not commissioned; externally peer reviewed.

Ethics statements

Patient consent for publication

Consent obtained directly from patient(s).

References

  • 1.Alarcón F, Zijlmans JCM, Dueñas G, et al. Post-Stroke movement disorders: report of 56 patients. J Neurol Neurosurg Psychiatry 2004;75:1568–74. 10.1136/jnnp.2003.011874 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.D'Olhaberriague L, Arboix A, Martí-Vilalta JL, et al. Movement disorders in ischemic stroke: clinical study of 22 patients. Eur J Neurol 1995;2:553–7. 10.1111/j.1468-1331.1995.tb00173.x [DOI] [PubMed] [Google Scholar]
  • 3.Kim JS. Involuntary movements after anterior cerebral artery territory infarction. Stroke 2001;32:258–61. 10.1161/01.str.32.1.258 [DOI] [PubMed] [Google Scholar]
  • 4.Bhatia KP. The paroxysmal dyskinesias. J Neurol 1999;246:149–55. 10.1007/s004150050325 [DOI] [PubMed] [Google Scholar]
  • 5.Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 1995;38:571–9. 10.1002/ana.410380405 [DOI] [PubMed] [Google Scholar]
  • 6.Bruno MK, Hallett M, Gwinn-Hardy K, et al. Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology 2004;63:2280–7. 10.1212/01.wnl.0000147298.05983.50 [DOI] [PubMed] [Google Scholar]
  • 7.Strzelczyk A, Bürk K, Oertel WH. Treatment of paroxysmal dyskinesias. Expert Opin Pharmacother 2011;12:63–72. 10.1517/14656566.2010.513971 [DOI] [PubMed] [Google Scholar]
  • 8.Cao L, Huang X, Wang N, et al. Recommendations for the diagnosis and treatment of paroxysmal kinesigenic dyskinesia: an expert consensus in China. Transl Neurodegener 2021;10:7. 10.1186/s40035-021-00231-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Camac A, Greene P, Khandji A. Paroxysmal kinesigenic dystonic choreoathetosis associated with a thalamic infarct. Mov Disord 1990;5:235–8. 10.1002/mds.870050309 [DOI] [PubMed] [Google Scholar]
  • 10.Zenzola A, De Mari M, De Blasi R, et al. Paroxysmal dystonia with thalamic lesion in multiple sclerosis. Neurol Sci 2001;22:391–4. 10.1007/s100720100070 [DOI] [PubMed] [Google Scholar]
  • 11.Gupta N, Pandey S. Post-Thalamic stroke movement disorders: a systematic review. Eur Neurol 2018;79:303–14. 10.1159/000490070 [DOI] [PubMed] [Google Scholar]
  • 12.Klein C, Münchau A. Progressive dystonia. In: Handbook of clinical neurology. Elsevier, 2013: 1889–97. [DOI] [PubMed] [Google Scholar]
  • 13.Herzog R, Weissbach A, Bäumer T, et al. Complex dystonias: an update on diagnosis and care. J Neural Transm 2021;128:431–45. 10.1007/s00702-020-02275-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Lee MS, Marsden CD. Movement disorders following lesions of the thalamus or subthalamic region. Mov Disord 1994;9:493–507. 10.1002/mds.870090502 [DOI] [PubMed] [Google Scholar]
  • 15.Trepel M, Mayer-Fally E. Neuroanatomie. In: Struktur und Funktion. 18. 7 edn. München: Elsevier, 2017: 35. 10.1016/S1615-9071(17)30021-7 [DOI] [Google Scholar]
  • 16.Argyelan M, Carbon M, Niethammer M, et al. Cerebellothalamocortical connectivity regulates penetrance in dystonia. J Neurosci 2009;29:9740–7. 10.1523/JNEUROSCI.2300-09.2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kim JH, Kim D-W, Kim JB, et al. Thalamic involvement in paroxysmal kinesigenic dyskinesia: a combined structural and diffusion tensor MRI analysis. Hum Brain Mapp 2015;36:1429–41. 10.1002/hbm.22713 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Picillo M, Paramanandam V, Morgante F, et al. Dystonia as complication of thalamic neurosurgery. Parkinsonism Relat Disord 2019;66:232–6. 10.1016/j.parkreldis.2019.08.008 [DOI] [PubMed] [Google Scholar]
  • 19.Liu W, Xiao Y, Zheng T, et al. Neural mechanisms of paroxysmal kinesigenic dyskinesia: insights from neuroimaging. J Neuroimaging 2021;31:272–6. 10.1111/jon.12811 [DOI] [PubMed] [Google Scholar]
  • 20.Benabid AL, Chabardes S, Mitrofanis J. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson’s disease. 8, 2009: 15. [DOI] [PubMed] [Google Scholar]
  • 21.Nijssen PC, Tijssen CC. Stimulus-Sensitive paroxysmal dyskinesias associated with a thalamic infarct. Mov Disord 1992;7:364–6. 10.1002/mds.870070412 [DOI] [PubMed] [Google Scholar]
  • 22.Zittel S, Bester M, Gerloff C, et al. Symptomatic paroxysmal kinesigenic choreoathetosis as primary manifestation of multiple sclerosis. J Neurol 2012;259:557–8. 10.1007/s00415-011-6188-5 [DOI] [PubMed] [Google Scholar]
  • 23.Buhmann C, Rizos A, Emmans D. Interkulturelle adaption Der aims in deutscher Sprache: Eine Skala für abnorme unwillkürliche Bewegungen. Nervenarzt 2016;87:411–7. [DOI] [PubMed] [Google Scholar]
  • 24.Méneret A, Roze E. Paroxysmal movement disorders: an update. Rev Neurol 2016;172:433–45. 10.1016/j.neurol.2016.07.005 [DOI] [PubMed] [Google Scholar]
  • 25.Blakeley J, Jankovic J. Secondary paroxysmal dyskinesias. Mov Disord 2002;17:726–34. 10.1002/mds.10178 [DOI] [PubMed] [Google Scholar]
  • 26.Volkmann J, Fogel W, Krack P. Postoperatives neurologisches management bei stimulation des nucleus subthalamicus. Akt Neurol 2000;27:S23–39. 10.1055/s-2007-1017592 [DOI] [Google Scholar]
  • 27.Cury RG, Fraix V, Castrioto A, et al. Thalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystonia. Neurology 2017;89:1416–23. 10.1212/WNL.0000000000004295 [DOI] [PubMed] [Google Scholar]
  • 28.Koeglsperger T, Palleis C, Hell F, et al. Deep brain stimulation programming for movement disorders: current concepts and evidence-based strategies. Front Neurol 2019;10:410. 10.3389/fneur.2019.00410 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Raina GB, Cersosimo MG, Folgar SS, et al. Holmes tremor: clinical description, lesion localization, and treatment in a series of 29 cases. Neurology 2016;86:931–8. 10.1212/WNL.0000000000002440 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Han S, Wang X, Xu K, et al. Crossed cerebellar diaschisis: three case reports imaging using a Tri-Modality PET/CT-MR system. Medicine 2016;95:e2526. 10.1097/MD.0000000000002526 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Ford AA, Triplett W, Sudhyadhom A, et al. Broca's area and its striatal and thalamic connections: a diffusion-MRI tractography study. Front Neuroanat 2013;7:8. 10.3389/fnana.2013.00008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Jonas S. The thalamus and aphasia, including transcortical aphasia: a review. J Commun Disord 1982;15:31–41. 10.1016/0021-9924(82)90042-9 [DOI] [PubMed] [Google Scholar]
  • 33.Fritsch M, Krause T, Klostermann F, et al. "Thalamic aphasia" after stroke is associated with left anterior lesion location. J Neurol 2020;267:106–12. 10.1007/s00415-019-09560-1 [DOI] [PubMed] [Google Scholar]
  • 34.Mink JW. Treatment of paroxysmal dyskinesias in children. Curr Treat Options Neurol 2015;17:23. [DOI] [PubMed] [Google Scholar]
  • 35.Huang Y-G, Chen Y-C, Du F, et al. Topiramate therapy for paroxysmal kinesigenic choreoathetosis. Mov Disord 2005;20:75–7. 10.1002/mds.20283 [DOI] [PubMed] [Google Scholar]
  • 36.Matsuura R, Hamano S-I, Hiwatari E, et al. Zonisamide therapy for patients with paroxysmal kinesigenic dyskinesia. Pediatr Neurol 2020;111:23–6. 10.1016/j.pediatrneurol.2020.06.017 [DOI] [PubMed] [Google Scholar]
  • 37.Mehta SH, Morgan JC, Sethi KD. Paroxysmal dyskinesias. Curr Treat Options Neurol 2009;11:170–8. 10.1007/s11940-009-0020-x [DOI] [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES